Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-111-0 | CAS number: 64742-11-6 A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key acute oral (similar to OECD 401), dermal (similar to OECD 402), and inhalation (OECD 403) toxicity studies (OECD 420) were identified.
• The oral LD50 was > 5000 mg/kg bw in male and female rats for light paraffinic DAE.
• The inhalation LC50 was > 5 mg/L for DAE.
• The dermal LD50 was > 3000 mg/kg/bw in male and female rabbits for light paraffinic DAE.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- one of seven studies showing similar results.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 5 000 mg/m³ air
- Quality of whole database:
- two studies availble that give the same results
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- one of seven studies showing similar results.
Additional information
Key oral, dermal, and inhalation toxicity studies were identified for distillate aromatic extracts.
Acute Oral Toxicity
In an acute oral toxicity study, groups of fasted, 7 week old Sprague-Dawley rats (5/sex) were given a single oral dose of undiluted light paraffinic distillate solvent at a dose of 5000 mg/kg body weight (API, 1986). Animals were observed for 14 days. Clinical signs observed included: hypoactivity, ataxia, red stained face, yellow-stained anal area, diarrhoea, and oily haircoat. All animals had returned to normal within 8 days of test material administration. The oral LD50 was determined to be greater than 5000 mg/kg body weight in males and females.
Acute Inhalation Toxicity
In an acute inhalation toxicity study, groups of young adult Sprague Dawley rats (5/sex) were exposed by inhalation route to distillate aromatic extract (aerosol) for 4 hours to whole body at a concentrations of 5.0 mg/L (ARCO, 1983a). Animals then were observed for 14 days. All animals were lethargic during the last 2 hours of exposure. From hour 2 of treatment until the first hour post-exposure, animals kept their eyes partially closed and were lacrimating. One rat displayed red nasal discharge following exposure and red ocular discharge. Another rat exhibited yellow eye discharge during the fourth hour post-exposure and red eye discharge the morning following treatment until the end of the third day post-treatment. These findings are considered related to treatment. Three rats of each sex showed pallor and/or swelling of the kidneys. These findings may be related to treatment. The acute aerosol LD50 of distillate aromatic extract is greater than 5.0 mg/L of air.
Acute Dermal Toxicity
In an acute dermal toxicity study, groups of New Zealand White rabbits (8/sex) were dermally exposed to undiluted light paraffinic distillate solvent extract for 24 hours to 10% of total body area at doses of 2000 and 3000 mg/kg bw (API, 1986). Animals then were observed for 14 days. At the 2000mg/kg bw dosage level: diarrhoea, dyspnoea, hypoactivity, prostration, emaciation, soft stool. At the 3000mg/kg bw dosage level: no signs of systemic toxicity (or mortality). Dermal irritation was observed and ranged from slight to severe for erythema and oedema. The dermal LD50 was determined to be greater than 3000 mg/kg body weight in both males and females.
Additional data supports that DAE is not an acute oral (ARCO, 1973c; ARCO, 1982a; ARCO, 1983b, c, d, e; ARCO, 1985b; , inhalation (ARCO, 1983e), or dermal (ARCO, 1973a; ARCO, 1982d; ARCO, 1984b, c, d; ARCO, 1985a;) toxicant. This information is presented in the dossier.
Justification for selection of acute toxicity – oral endpoint
one of 7 acute oral toxicity studies showing LD50 values > 5000 mg/kg
Justification for selection of acute toxicity – inhalation endpoint
one of 2 studies giving similar results
Justification for selection of acute toxicity – dermal endpoint
one of 7 acute oral toxicity studies showing LD50 values > 2000 mg/kg
Justification for classification or non-classification
Based on evaluation of all the acute toxicity data discussed above, DAE does not meet the criteria for classification as an acute oral, inhalation or dermal toxicant under the EU CLP Regulation (EC No. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
